- Home
- About Us
- Our Products
- Investors
- News
- New Product Pipeline
- Contact Us
Read Appendix 3Y - sale of 500,000 shares by Dr Alan Robertson.
As further explanation to the market at this time, Dr Robertson has advised that the shares were sold in order to fund a tax liability arising from the exercise of expiring options in November 2009.